Journal
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Volume 81, Issue 1, Pages 76-90Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2019.02.067
Keywords
acne inversa; adalimumab; biomarkers; carbon dioxide laser; clindamycin; comorbidities; ertapenem; finasteride; guidelines; hidradenitis suppurativa; infliximab; laser; lifestyle modification; microbiome; Nd:YAG; oral contraceptive pills; rifampin; spironolactone
Categories
Ask authors/readers for more resources
Hidradenitis suppurativa is a chronic inflammatory disorder affecting hair follicles, with profoundly negative impact on patient quality of life. Evidence informing ideal evaluation and management of patients with hidradenitis suppurativa is still sparse in many areas, but it has grown substantially in the last decade. Part I of this evidence-based guideline is presented to support health care practitioners as they select optimal management strategies, including diagnostic testing, comorbidity screening, and both complementary and procedural treatment options. Recommendations and evidence grading based on the evidence available at the time of the review are provided.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available